Clinical Trials on Carcinoma, Ovarian Epithelial in United Kingdom
Total 14592 results
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedSolid TumorsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Recurrent Ovarian Epithelial Cancer | Recurrent Ovarian Germ Cell Tumor | Stage IIIA Ovarian Germ Cell Tumor | Stage IIIB Ovarian Germ Cell... and other conditionsUnited States
-
Michael McHaleVerastem, Inc.; Nine Girls AskRecruitingROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAKOvarian CancerUnited States
-
Winthrop University HospitalCompleted
-
Roswell Park Cancer InstituteActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Platinum-Sensitive Ovarian Carcinoma | Refractory Ovarian... and other conditionsUnited States
-
Hoosier Cancer Research NetworkBoehringer IngelheimTerminated
-
Swedish Medical CenterAstraZenecaUnknownUterine Cancer | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
Azaya Therapeutics, Inc.UnknownCancer | Ovarian Cancer | Ovarian Epithelial Cancer Recurrent | Malignant Female Reproductive System Neoplasm | Ovarian TumorCanada, United States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma and other conditionsUnited States
-
Gradalis, Inc.CompletedStage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI)Recruiting
-
PfizerTerminatedOvarian Neoplasms | Ovarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Ovarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Astellas Pharma IncCompletedOvarian Cancer | Solid TumorsUnited States, United Kingdom, Australia, Canada, Switzerland, Czechia, Italy, Poland, Romania, Russian Federation
-
NYU Langone HealthGenentech, Inc.; University of New Mexico Cancer CenterCompleted
-
Swedish Medical CenterGlaxoSmithKlineCompletedStage IV Breast Cancer | Stage IV Ovarian Cancer | Ovarian Epithelial Cancer Stage IIIUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedOvarian CancerUnited States, Canada
-
Duke UniversityCompletedPalliative Care | Platinum-resistant Ovarian Cancer | Recurrent Ovarian CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Undifferentiated Ovarian CarcinomaUnited States
-
Walter and Eliza Hall Institute of Medical ResearchJohns Hopkins UniversityActive, not recruitingOvarian CancerAustralia, United States
-
Jason D. WrightGenentech, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
Fox Chase Cancer CenterCompletedFallopian Tube Cancer | Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Ellipses PharmaCompletedOvarian CancerUnited States, United Kingdom, Hungary
-
Medical Research CouncilEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerSpain, Belgium, France, Netherlands, Austria, United Kingdom, Italy, South Africa, Portugal, Ireland
-
New Mexico Cancer Care AllianceGenentech, Inc.; NYU Langone HealthCompletedOvarian CancerUnited States
-
Pine Street FoundationCompletedOvarian CancerUnited States
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)TerminatedMaveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer (AVALON)Platinum-resistant Epithelial Ovarian CancerUnited States, Canada, Puerto Rico
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
TetraLogic PharmaceuticalsCompletedRelapsed Epithelial Ovarian Cancer | Relapsed Primary Peritoneal Cancer | Relapsed Fallopian Tube CancerUnited States
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT)Active, not recruitingOvarian Neoplasms | Ovarian, Fallopian Tube and Primary Peritoneal CarcinomaUnited States, Netherlands, Spain, Finland, Italy, Poland, Belgium, Canada, France, Germany, Romania, Ukraine, Norway, United Kingdom, Israel, Greece, Denmark, Belarus, Czechia
-
Dana-Farber Cancer InstituteImmunityBio, Inc.Not yet recruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Ovarian Carcinoma | Recurrent Ovary Cancer | Ovarian Carcinoma, RecurrentUnited States
-
Eli Lilly and CompanyCompletedOvarian CancerUnited States, Israel, Spain, Korea, Republic of, Australia, Belgium, United Kingdom, Italy
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedOvarian NeoplasmUnited States, Spain, Australia, Germany, Sweden
-
Duke UniversityJohns Hopkins University; Genentech, Inc.CompletedOvarian Neoplasms | Ovarian CancerUnited States
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
Prescient Therapeutics, Ltd.Terminated
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseTerminatedOvarian CancerUnited States
-
University of Texas Southwestern Medical CenterOrtho Biotech Clinical Affairs, L.L.C.WithdrawnOvarian CancerUnited States
-
Massachusetts General HospitalUniversity of California, IrvineUnknown
-
H. Lee Moffitt Cancer Center and Research InstituteUniversity of South FloridaCompletedOvarian CancerUnited States
-
NYU Langone HealthWithdrawnOvarian CancerUnited States
-
Cellectar Biosciences, Inc.Massachusetts General Hospital; Dana-Farber Cancer InstituteCompletedOvarian CancerUnited States
-
Indiana UniversityEisai Inc.CompletedOvarian CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
National Cancer Institute (NCI)Completed
-
University of Alabama at BirminghamNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal CancerUnited States
-
Fujirebio Diagnostics, Inc.Completed
-
On Target Laboratories, LLCSynteractHCRCompletedOvarian CancerUnited States
-
Tesaro, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Duke UniversityCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States